Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This ...

Shares of Clover Health Investments plummeted more than 20 percent at one point Wednesday afternoon, a day after the Franklin-based health insurance company reported second-quarter results. Online ...

Clover Health Investments CLOV is slated to release second-quarter 2025 results on Aug. 5, after market close. The Zacks Consensus Estimate for earnings and revenues is pegged at 3 cents per share and ...

Clover Health Investments, Corp. (CLOV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

Shares of Clover Health (CLOV) plunged ~20% on Wednesday following the company’s Q3 2025 results, as the health insurer sharply lowered its full-year guidance for adjusted EBITDA despite increasing ...

Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.01 per share a year ago. These ...

Clover Health has improved margins and grown Medicare Advantage membership but still posts losses. The company’s tech focus, including Clover Assistant, is promising but not yet proven at scale. Most ...

Clover Health Investments (CLOV) has been treading water in the short term, but its mix of faster revenue growth and shrinking losses has some investors revisiting the stock after a choppy past 3 ...

Clover Health co-founder and President Andrew Toy will take the reins as CEO of the insurtech company when current CEO Vivek Garipalli transitions out of the role at the end of the year. Garipalli ...